Results 51 to 60 of about 24,341 (292)

How I treat thrombotic thrombocytopenic purpura and atypical haemolytic uraemic syndrome [PDF]

open access: yes, 2014
Thrombotic thrombocytopenic purpura (TTP) and atypical haemolytic uraemic syndrome (aHUS) are acute, rare life-threatening thrombotic microangiopathies that require rapid diagnosis and treatment.
Goodship, T, Scully, M
core   +1 more source

Atypical Hemolytic Uremic Syndrome after SARS-CoV-2 Infection: Report of Two Cases

open access: yesInternational Journal of Environmental Research and Public Health, 2022
Atypical hemolytic uremic syndrome (aHUS) is a life-threatening disease causing systemic thrombotic microangiopathy (TMA) due to the fact of complement dysregulation.
Iwona Smarz-Widelska   +4 more
semanticscholar   +1 more source

Pregnancy in Women with Atypical Hemolytic Uremic Syndrome [PDF]

open access: yesNephron, 2021
<b><i>Background:</i></b> Pregnancy outcomes in patients with atypical hemolytic uremic syndrome (aHUS) are not well-documented. Here, we present characteristics of and outcomes for patients with aHUS who became pregnant while enrolled in the Global aHUS Registry.
Benjamin Miller   +7 more
openaire   +2 more sources

An expert discussion on the atypical hemolytic uremic syndrome nomenclature-identifying a road map to precision: a report of a National Kidney Foundation Working Group. [PDF]

open access: yes
The term atypical hemolytic uremic syndrome has been in use since the mid-1970s. It was initially used to describe the familial or sporadic form of hemolytic uremic syndrome as opposed to the epidemic, typical form of the disease. Over time, the atypical
Burwick, R.   +24 more
core   +4 more sources

Atypical hemolytic uremic syndrome induced by SARS-CoV2 infection in infants with EXOSC3 mutation

open access: yesPediatric nephrology (Berlin, West), 2022
Atypical hemolytic uremic syndrome (aHUS) is a rare disease characterized by systemic thrombotic microangiopathy mainly in the kidneys and mostly due to genetic disorders leading to uncontrolled activation of the complement system.
Chantal Van Quekelberghe   +4 more
semanticscholar   +1 more source

Complement and the atypical hemolytic uremic syndrome in children [PDF]

open access: yesPediatric Nephrology, 2008
AbstractOver the past decade, atypical hemolytic uremic syndrome (aHUS) has been demonstrated to be a disorder of the regulation of the complement alternative pathway. Among approximately 200 children with the disease, reported in the literature, 50% had mutations of the complement regulatory proteins factor H, membrane cofactor protein (MCP) or factor
Véronique Frémeaux-Bacchi   +2 more
openaire   +3 more sources

Atypical Hemolytic Uremic Syndrome

open access: yesPediatric Clinics of North America, 2018
Atypical hemolytic uremic syndrome is a rare life-threatening disease of unregulated complement activation. Untreated, the prognosis is generally poor; more than one-half of patients die or develop end-stage renal disease within 1 year. Atypical hemolytic uremic syndrome is characterized by thrombotic microangiopathy with evidence of hemolysis ...
Bradley P. Dixon, Ralph A. Gruppo
openaire   +5 more sources

Pregnancy-triggered atypical hemolytic uremic syndrome (aHUS): a Global aHUS Registry analysis

open access: yesJN. Journal of Nephrology (Milano. 1992), 2021
Atypical hemolytic uremic syndrome (aHUS) is a rare disease in which uncontrolled terminal complement activation leads to systemic thrombotic microangiopathy (TMA).
F. Fakhouri   +5 more
semanticscholar   +1 more source

CFHR Gene Variations Provide Insights in the Pathogenesis of the Kidney Diseases Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy.

open access: yesJournal of the American Society of Nephrology, 2020
Sequence and copy number variations in the human CFHR-Factor H gene cluster comprising the complement genes CFHR1, CFHR2, CFHR3, CFHR4, CFHR5, and Factor H are linked to the human kidney diseases atypical hemolytic uremic syndrome (aHUS) and C3 ...
P. Zipfel, T. Wiech, E. Stea, C. Skerka
semanticscholar   +1 more source

Phenotypic manifestation of homozygous partial deletion of the chromosome 1 segment spanning CFHR3 region

open access: yesМедицинская иммунология, 2020
This article presents two clinical cases of patients with a homozygous deletion of segment of chromosome 1, which covers regions of genes associated with complement factor H, in particular CFHR3.
I. A. Tuzankina   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy